Showing 11-20 of 33 results for "".
Maximizing Results: The Benefits of Biostimulators
https://practicaldermatology.com/conferences/asds-2022-annual-meeting/maximizing-results-the-benefits-of-biostimulators/20150/Patients often present with a desire for optimal results on a limited budget. Sabrina Fabi, MD shares how she effectively uses biostimulators in her practice. For low-volume, high-yield results, she recommends 1 vial every 8 months to a year. Alternating this with hyaluronic acid fillers, keeps everWondering with Steve and Sabrina: Mexico
https://practicaldermatology.com/topics/skin-cancer-photoprotection/wondering-with-steve-and-sabrina-mexico/18646/Traveling in the Baja Desert, Steven Dayan, MD and Sabrina Fabi, MD discover the benefits of Lomboy, a plant that can be used for sun protection. While natural isn't always better (think poison ivy), Lomboy is widely used to protect the skin because it produces a thick white paste. (C) Steven Dayan,Optimizing Injectable Results
https://practicaldermatology.com/conferences/asds-2021/optimizing-injectable-results/20021/When it comes to injectables and facial rejuvenation, a panfacial approach can lead to optimal results. But not all patients have the budget for that. Sabrina Fabi, MD shares tips for optimizing results with a low-volume/high-yield treatment plan.- Galderma's Sculptra Now FDA Approved for Cheek Wrinkleshttps://practicaldermatology.com/news/galdermas-sculptra-now-fda-approved-for-cheeks/2461683/The U.S. Food and Drug Administration (FDA) has approved Sculptra (injectable poly-L-lactic acid (PLLA-SCA)) for the correction of fine lines and wrinkles in the cheek area. Sculptra is the first FDA-approved PLLA collagen stimulator that helps stimulate natural collagen production in the cheeks wi…
- Mayne Pharma's Lexette Approved for Adolescentshttps://practicaldermatology.com/news/mayne-pharmas-lexette-approved-for-adolescents/2460921/Lexette® (halobetasol propionate) foam, 0.05% from Mayne Pharma is now approved for the treatment of plaque psoriasis in patients aged 12 years and older. FDA approved Lexette in 2018 for use in adults. Approval in adolescents is based on data obtained in an open label follow-on study to the init…
- Allergan Aesthetics Introduces CoolSculpting Elitehttps://practicaldermatology.com/news/allergan-aesthetics-introduces-coolsculpting-elite/2460667/Allergan Aesthetics, an AbbVie company, is launching CoolSculptingElite, its next generation fat reduction system with applicators designed to complement the body's natural curves. The system will launch with a new applicator collection, which includes seven different shapes and sizes. The innova…
- FDA Approves Sorilux for Adolescent Plaque Psoriasishttps://practicaldermatology.com/news/fda-approves-sorilux-for-adolescent-plaque-psoriasis/2460039/The FDA has approved Mayne Pharma Group Limited's Sorilux (calcipotriene) Foam, 0.005% in adolescents 12 years and older. The FDA approved Sorilux in 2010 based on evidence from two eight-week placebo controlled clinical trials in patients with mild to moderate plaque psoriasis of the body and one…
- Allergan 360° Aesthetics Report Shines Light on Evolving Beauty Perceptions Around the Worldhttps://practicaldermatology.com/news/allergan-3600-aesthetics-report-shines-light-on-evolving-beauty-perceptions-around-the-world/2459994/The digital boom and millennials are growing the aesthetics category, and wellness and self-care are the new key drivers, according to the Allergan 360° Aesthetics Report. To develop the report, Allergan tapped into more than 14,500 aesthetically conscious consumers and 1,300 aesthetic physicians …
- Study: Positive Safety and Tolerability Results for Ortho Dermatologics' Altreno for Acnehttps://practicaldermatology.com/news/study-positive-results-for-ortho-dermatologics-altrenos-safety-and-tolerability-for-acne/2457569/Ortho Dermatologics shared results of two identical Phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel group studies examining the efficacy and safety of Altreno (tretinoin) Lotion, 0.05%, the first formulation of tretinoin, a retinoid, in a lotion indicated for the topica…
- Allergan's SkinMedica Tackles Blue Light and More with New LUMIVIVE Systemhttps://practicaldermatology.com/news/skinmedica-tackles-blue-light-and-more-with-new-lumivie-system/2457620/Allergan is launching the SkinMedica LUMIVIVE System, with two distinct formulas - one to shield skin from blue light and environmental aggressors during the day and another to recharge the skin's repair process at night for 24-hour protection and revitalization. "Skin today is under attack from m…